Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
NCT ID: NCT06089161
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
330 participants
INTERVENTIONAL
2024-03-19
2028-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Health Education and Social Support Among Blacks With OSA
NCT02628977
Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome
NCT01946659
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
NCT03256539
Sleep Apnea and Cognitive Function in Subjects With Subjective or Mild Cognitive Impairment
NCT06089096
Feasibility of Improving Sleep Apnea Treatment Adherence After Brain Injury
NCT04221009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care Group
Participants in this group receive the standard of care treatment for sleep apnea for up to six months.
Standard of Care
Participants in this group will receive standard of care treatment for sleep apnea.
Personalized OSA Treatment Group
Participants in this group receive personalized OSA treatment for sleep apnea for up to six months.
Standard of Care
Participants in this group will receive standard of care treatment for sleep apnea.
Personalized OSA Treatment
Participants in this group will receive standard of care treatment plus the personalized treatment that consists of videos approximately three minutes long, virtual, accessed through web based application, that the participant watches weekly. The purpose of the video is tailored educational content for sleep apnea.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of Care
Participants in this group will receive standard of care treatment for sleep apnea.
Personalized OSA Treatment
Participants in this group will receive standard of care treatment plus the personalized treatment that consists of videos approximately three minutes long, virtual, accessed through web based application, that the participant watches weekly. The purpose of the video is tailored educational content for sleep apnea.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 60-85 years
* accessible by phone
* OSA diagnosis
* consent, including permission to release medical data
Exclusion Criteria
* impaired cognitive/ functional ability precluding participation
* intention to move within the year
* and a family member currently enrolled.
60 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Girardin Jean-Louis
Distinguished Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Girardin Jean-Louis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.